May Nesfatin-1 is a New Marker of Inflammation in Varicose Veins?
Öz
Objective: The expression of nesfatin-1, an anti-inflammatory peptide, in varicose saphenous veins, may indicate the inflammation process in these veins. For this purpose, we aimed to determine the presence nesfatin-1 in varicose veins.
Materials and methods: In this study, varicose vein samples have been taken from 50 patients with varicose veins. For the control group, vena saphena magna tissue samples taken out for coronary bypass were obtained from 50 patients. Immunohistochemical staining was performed by staining tissues with nesfatin-1 antibody and two groups were compared.
Results: In the immunostaining of nesfatin-1 on varicose vein samples, 38 (76%) patients were determined to be positive, and no staining was observed in 12 (24%) patients. In saphenous tissue samples taken from the control group, 10 samples (20%) were stained positive with nesfatin immunostaining, while 40 samples (80%) were not stained. Staining of varicose veins with nesfatin immunostaining showed a statistically significant difference compared to the staining of samples taken from the control group (p<0.0001).
Conclusion: When compared to healthy veins, it was demonstrated that the varicose
etiopathogenesis. It is concluded that the expression of nesfatin-1, which is an anti-inflammatory peptide, in varicose veins may be a response to the inflammatory process.
Anahtar Kelimeler
Kaynakça
- Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Comm Health. 1999;53:149-53.
- Chwała M, Szczeklik W, Szczeklik M, Aleksiejew-Kleszczynski T, Jagielska-Chwała M. Varicose veins of lower extremities, hemodynamics and treatment methods. Adv Clin Exp Med. 2015;24:5-14.
- Krysa J, Jones GT, van Rij AM. Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology. 2012;27:329-35.
- Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg. 1995;22:622–8.
- Jawien A. The influence of environmental factors in chronic venous insufficiency. Angiology. 2003;54: 19–31.
- Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem. 1984;30: 211-5.
- Rose SS, Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg. 1986;27(5):534-43.
- Birdina J, Pilmane M, Ligers A. The Morphofunctional Changes in the Wall of Varicose Veins. Ann Vasc Surg. 2017;42:274-84.
- Vural M, Toy H, Camuzcuoglu H, Aksoy N. Comparison of prolidase enzyme activities of maternal serum and placental tissue in patients with early pregnancy failure. Arch Gynecol Obstet. 2011;283:953-8.
- Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443(7112):709-12.